Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance
Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The psychedelic firm late on Friday
Read moreMind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The psychedelic firm late on Friday
Read moreMind Medicine (NEO: MMED) has officially seen patient trials under a Phase 2b study get underway as it looks to
Read more20-year-old Jake Freeman just walked away with around $110 million from selling his 6.21% stake in meme-stock favorite Bed Bath
Read moreMind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday its financial results for Q2 2022. The
Read moreAn activist shareholder battle might be brewing at Mind Medicine (NEO: MMED). This morning, co-founder of the company Dr Scott
Read moreIn a classic Canadian small cap move, Mind Medicine (NEO: MMED) last night announced that it’s directors have approved a
Read moreMind Medicine (NEO: MMED) last night announced that it will be conducting a financing. The company is looking to raise
Read moreField Trip Health (TSX: FTRP) is set to be split into two separate firms. The company last night indicated that
Read moreMydecine Innovations (NEO: MYCO) is the latest firm to announce a reverse stock split amid a recent trend amongst small
Read moreConsolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be
Read more